{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:10:32Z","timestamp":1791198632229,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Kocaeli University Research Fund"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physiology & Behavior"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.physbeh.2013.06.010","type":"journal-article","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T10:33:41Z","timestamp":1371119621000},"page":"145-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Effects of long-term etanercept treatment on anxiety- and depression-like neurobehaviors in rats"],"prefix":"10.1016","volume":"119","author":[{"given":"Dilek","family":"Bayramg\u00fcrler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fe","family":"Karson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00fcneyt","family":"\u00d6zer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tijen","family":"Utkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.physbeh.2013.06.010_bb0005","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1529-8019.2010.01312.x","article-title":"Psoriasis: depression, anxiety, smoking, and drinking habits","volume":"23","author":"Hayes","year":"2010","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.physbeh.2013.06.010_bb0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-244X-12-6","article-title":"Depression and anxiety in patients with rheumatoid arthritis: prevalence rates based on a comparison of the Depression, Anxiety and Stress Scale (DASS) and the Hospital, Anxiety and Depression Scale (HADS)","volume":"12","author":"Covic","year":"2012","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.physbeh.2013.06.010_bb0015","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jaad.2009.07.022","article-title":"The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial","volume":"62","author":"Menter","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.physbeh.2013.06.010_bb0020","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.eurpsy.2008.03.013","article-title":"Depression, comorbidities and the TNF-alpha system","volume":"23","author":"Himmerich","year":"2008","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.physbeh.2013.06.010_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/da.22084","article-title":"Cytokine targets in the brain: impact on neurotransmitters and neurocircuits","author":"Miller","year":"2013","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.physbeh.2013.06.010_bb0030","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Danzer","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.physbeh.2013.06.010_bb0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(05)67763-X","article-title":"Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial","volume":"367","author":"Tyring","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.physbeh.2013.06.010_bb0040","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1468-3083.2007.02310.x","article-title":"Infliximab for patients with plaque psoriasis and severe psychiatric comorbidity","volume":"22","author":"Bassukas","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.physbeh.2013.06.010_bb0045","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1440-0960.2008.00487.x","article-title":"Infliximab rescue of efalizumab withdrawal flare and psoriasis-precipitated depression","volume":"49","author":"Yip","year":"2008","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.physbeh.2013.06.010_bb0050","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1440-1819.2008.01905.x","article-title":"Anti-tumor necrosis factor-alpha therapy is associated with less frequent mood and anxiety disorders in patients with rheumatoid arthritis","volume":"63","author":"Uguz","year":"2009","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.physbeh.2013.06.010_bb0055","article-title":"Chronic administration of infliximab (TNF-\u03b1 inhibitor) decreases depression and anxiety-like behaviour in rat model of chronic mild stress","author":"Karson","year":"2012","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.physbeh.2013.06.010_bb0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.metabol.2005.01.011","article-title":"Depression, cytokines, and glial function","volume":"54","author":"Miller","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.physbeh.2013.06.010_bb0065","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.pnpbp.2004.11.003","article-title":"Cytokines and major depression","volume":"29","author":"Schiepers","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.physbeh.2013.06.010_bb0070","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0893-133X(99)00134-7","article-title":"Cytokine production and treatment response in major depressive disorder","volume":"22","author":"Lanquillon","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.physbeh.2013.06.010_bb0075","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.physbeh.2005.02.011","article-title":"Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia","volume":"84","author":"Grippo","year":"2005","journal-title":"Physiol Behav"},{"key":"10.1016\/j.physbeh.2013.06.010_bb0080","first-page":"4447","article-title":"Role of interleukin-1 beta and tumour necrosis factor-alpha in lipopolysaccharide-induced sickness behaviour: a study with interleukin-1 type I receptor-deficient mice","volume":"12","author":"Bluth\u00e9","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.physbeh.2013.06.010_bb0085","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1749-6632.2000.tb05412.x","article-title":"Illness, cytokines, and depression","volume":"917","author":"Yirmiya","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.physbeh.2013.06.010_bb0090","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4103\/0253-7613.77365","article-title":"Effect of quercetin on lipopolysaccharide induced-sickness behavior and oxidative stress in rats","volume":"43","author":"Sah","year":"2011","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.physbeh.2013.06.010_bb0095","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bbr.2011.01.018","article-title":"Inflammation modulates anxiety in an animal model of multiple sclerosis","volume":"220","author":"Peruga","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.physbeh.2013.06.010_bb0100","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbr.2011.07.006","article-title":"Pro- and anti-inflammatory cytokines expression in rat's brain and spleen exposed to chronic mild stress: involvement in depression","volume":"225","author":"You","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.physbeh.2013.06.010_bb0105","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.neuropharm.2011.08.018","article-title":"Depressive-like behavior induced by tumor necrosis factor-\u03b1 in mice","volume":"62","author":"Kaster","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.physbeh.2013.06.010_bb0110","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1358\/dot.2006.42.10.1025701","article-title":"Bupropion","volume":"42","author":"Wilkes","year":"2006","journal-title":"Drugs Today"},{"key":"10.1016\/j.physbeh.2013.06.010_bb0115","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.intimp.2005.12.007","article-title":"A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice","volume":"6","author":"Brustolim","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.physbeh.2013.06.010_bb0120","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00213-010-2094-2","article-title":"Neuropsychopharmacological effect of sesamol in unpredictable chronic mild stress model of depression: behavioral and biochemical evidences","volume":"214","author":"Kumar","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.physbeh.2013.06.010_bb0125","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/sj.npp.1301029","article-title":"The proinflammatory cytokines interleukin-1 beta and tumor necrosis factor-alpha activate serotonin transporters","volume":"31","author":"Zhu","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.physbeh.2013.06.010_bb0130","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.biopsych.2006.03.075","article-title":"Successful antidepressant therapy restores the disturbed interplay between TNF-alpha system and HPA axis","volume":"60","author":"Himmerich","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.physbeh.2013.06.010_bb0135","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1566-0702(00)00231-9","article-title":"Vagotomy attenuates the behavioural but not the pyrogenic effects of interleukin-1 in rats","volume":"85","author":"Luheshi","year":"2000","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.physbeh.2013.06.010_bb0140","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/jnnp-2011-301779","article-title":"Depression: an inflammatory illness?","volume":"83","author":"Krishnadas","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.physbeh.2013.06.010_bb0145","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00213-002-1341-6","article-title":"Increased extracellular serotonin level in rat hippocampus induced by chronic citalopram is augmented by subchronic lithium: neurochemical and behavioural studies in the rat","volume":"166","author":"Wegener","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.physbeh.2013.06.010_bb0150","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00213-009-1684-3","article-title":"Acute administration of leptin produces anxiolytic-like effects: a comparison with fluoxetine","volume":"207","author":"Liu","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.physbeh.2013.06.010_bb0155","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.neuropharm.2012.06.066","article-title":"Blockade of the GABA(B) receptor increases neurogenesis in the ventral but not dorsal adult hippocampus: relevance to antidepressant action","volume":"63","author":"Felice","year":"2012","journal-title":"Neuropharmacology"}],"container-title":["Physiology & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938413001960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938413001960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T06:18:44Z","timestamp":1715494724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031938413001960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":31,"alternative-id":["S0031938413001960"],"URL":"https:\/\/doi.org\/10.1016\/j.physbeh.2013.06.010","relation":{},"ISSN":["0031-9384"],"issn-type":[{"value":"0031-9384","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of long-term etanercept treatment on anxiety- and depression-like neurobehaviors in rats","name":"articletitle","label":"Article Title"},{"value":"Physiology & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.physbeh.2013.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}